Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Roivant Sciences (ROIV) Research & Development: 2021-2025

Historic Research & Development for Roivant Sciences (ROIV) over the last 5 years, with Mar 2025 value amounting to $550.4 million.

  • Roivant Sciences' Research & Development rose 15.02% to $164.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $602.2 million, marking a year-over-year increase of 23.77%. This contributed to the annual value of $550.4 million for FY2025, which is 25.12% up from last year.
  • Latest data reveals that Roivant Sciences reported Research & Development of $550.4 million as of FY2025, which was up 25.12% from $439.9 million recorded in FY2024.
  • Roivant Sciences' Research & Development's 5-year high stood at $550.4 million during FY2025, with a 5-year trough of $236.6 million in FY2021.
  • Over the past 3 years, Roivant Sciences' median Research & Development value was $454.1 million (recorded in 2023), while the average stood at $481.5 million.
  • In the last 5 years, Roivant Sciences' Research & Development spiked by 104.13% in 2022 and then declined by 6.00% in 2023.
  • Roivant Sciences' Research & Development (Yearly) stood at $236.6 million in 2021, then spiked by 104.13% to $483.0 million in 2022, then decreased by 6.00% to $454.1 million in 2023, then fell by 3.12% to $439.9 million in 2024, then climbed by 25.12% to $550.4 million in 2025.